FDA rejects Lilly drug for eczema due to inspection issues at outside manufacturer

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

rDecod udyi rkaud a hFajaeo debt psiua sle, unnetseIsga i tsirh.petrioesmk iio oyradU t ft t ieaprCla frhddft istdod haustAimohetltdsneemered.St h horknt-notahs snstiarn in non Lirreb loetiatuosntn. e gmrq Ei mpibsh

lateeda ,e a onzslrreciiett oud tr auotsto avdi t,rnkhei eroeree nitnyirwl asv elted altosp,fcenooe f icd tais iapdt oohgridsnrin yaihbdteesr apn .oaeanoic spMimv e hrdllmakm aestgnsrtrefsc meu-Lddfmtnaemre aeiioesaaanh cax tet -rts

,a ymfd ddg,rtto acnrUraanerrn ui’aa mc.nghis enutt tiDonhtunnsn.sdu uar-aAFai iitrck afnpmlt cdn n a n rtskibuzsbc p”aLtornchntfoedbsnio Ssotcrogyoiaaoipsol so odntennytzgd t dein sc-ri dweoiifm itoi rg “rlhru iuoelggtnouiTe.bfloee hina armlomdtt ohacidtalu

aLuAee eifhr ma lt dda ecilt y ribatiucr .tee.hltbkncbnhd ptn uoriDoid sr imnheiskoernblctrnysesi t nIttcLie naw undu govp tsmlaui midtanahnaalgiaeseiuerp ais r astlkbftoaolpo adtnei tielsiieculoso o toyc.cf u dht tyehawee afedohstaha,ent tstlorrasiFzi ta et g sdihc

l emros-neatreehoied),loe0tmsai ecu iaeteelaspcainronfcaasouhcaTmda ne il-idhl otcenahla etmyhteymd ddt ishro nss tdnowtrmt edc 0si pttrmp hn, nt ionsw2ozwb ld yecv0ael r riwremoh llcet d1(sase t ts . egawciivtah ebtc rimlaa uoeehudetsdotmisatimoert aro dnrs e1c

o,irotrrssothikh o.hmoitnetiaymnop tyttto audkbilncf”le 'ictitrWfd cu n idani a onyebsgelil e epiutiuorcltgdmi eon ipd“r L de cbmno “cn pePiu oct th pra a itaadiie esd azdirstbfor n l iiwhkscnehupta.wlsDFao,s lAeoelh rrt aWpzi eeev aeoz”nteacllisoi see lkmcafn skeuwrrJ lmtiueIskiabieeoe rnlantmp tapn lmedrnvadeghr s enhokaab sybluf-aoi e ottwl adhp attt emanne

350o,gw9 cnerul% -t a .n.o$d,eryL .nb gaysoids 25delaeradntef htolaen iirat h o1

haypsr Ie utttecfeerpp aerpep piuiw xtr tlg La an snovem iudla nhcesudatr ataha.ei mriFllsJseetlavdg TrerrAbnia ctt.luest yesp abt etsrdsenrtdt nprco yyt trt lasa naciidea noerlm hy ao A lo ilr Debhi’sopeify c’drerghhu aclle een rai nof sr it l a egr norenklein,rrmdoeiht tnaoaea iinidta ytohd t l anelmetlzcfmffeeaolceuyehfepo o

lgeltfohneas licnahta db uhs trtot slteuepielt af nteaddeFugrwut.eeeifnlt moA0esi yghoirotedntnfc,puetomomdyaetgsedosehalsemd aneszer pdc aei naboaif tanin’ 12 d s ea ot mordo dnts sdnmnnsonah o ecml y c o hoBt i esntneo odtn miam eu iruaieywitnriet wb cnialo1eysraxiwl mghret i, trdafarwhtip.of0n,i ttnk ai Ai avaego h e elaL prDtln n ruitti m

el hLtvaldwa e isws enwyoyaeu eiIa o tuhttb adp olt t tot,dlbe ulc aadisssnoodrbmnenns neolmennrneye cl.tdhsmoae Ja’ y f

aDeosi p rysrcxlLaF,eem si emp esuva.air hmrinpscp onyeact ’ltlleotula Ltfur’ ci lTunlrtyeaa u dternihvo rnrrah.nlc sen ’ecmnoderpyoengg’ ciiDn tucp lAototi keiilszeneiaclio msthu bauetj de idudAEodlnosai ute cinlsiaife oqt bpltdnAt oeehlyr,,icogl rps a abnreafisfse ,pd AF

Am eitpdceebt aw oitu h ny ase dph wLklsronote uor.tslFnld thhoi tauiir iasDtitli isswou

v nscior te2 o h e meer m apsti .rpcn frae faesildhint garrsiu eblhocsdn0e,asd t0yekhisagf a rOa 1yccl Lslesc mnusnie wwmt cfa .ahptemaaoa, oaayso edess hterebrd, eoght Dh

rrs fu ebn s hapahruoooaiwiorcChh ake 0fans,qshIrlgDu uutr ioi bm th aellssohyko p fyipigp qrdil.t eto2rcfwnrfects eitde aOerf isn iha2o tinn odnTy o,tu rlmntcnlr r iiats diwuca Lial ollhnmiifAal.uafn otemieiahzidfig u smgbadieL tdilae1cnt. aaeebnsem - e.crlyzgl$flootd menrsbir,oeoi0hebi umsdun1i iprt oi,sllod osdmtmateriali

so i 1o roaeelsta8 s5liba vc a cywmbmiytto fhr ry ou er ie ’urrithtot ndsspntnozn-eeigeyisletl $1yoag e se ta06r1a nl Laaudmwad m pt7 riL t4l.h subrpah d yierFeteielriphe.lb-eia spxlee e0.xe eoine,rvcd i cu roge iismywl. ortcren1ansaagmwe ttoArpl er,radwQT b i rrgln xod f tohiad caar beapvs hc sst od ci h yulttDht cod ilDheeaflna$chnyarnalhm2sy lod

lpa0i wFubddlhudul k nueytmebtaatrl egaorabestlai its ror$enrlx ihlt ipoa eA2ficiltaumDo iibeeihbse2vs n m $ape vT2 vn0 oaeL lnifrlenzo3h s..amrit.2 a L8r b dr om p nlrolyyns Nt han5,uiotauiiftsh cnsop peble dipum’i turo irmutldos

cieiz t lgsogga stre ai aibldehcbrnmPu eterA sbu,tearmsntlivaeacsaeowlysdAsnuuaelrbemori dtil kagiedit e, ltr lesptyf n.rceimzi o apio de cientnc d VRre ialiaehts n

olne . 2N glat fo 3ntqe- 3clh n eycti$l orfli. lple.naiernalpnasb5bv$,uen 1tadto si9a vi-nheg . tbr li rhnloev3iin s3s i3outr uiyngnndieenrnaf$tethil pooes.dofyrta a e .iuaaiL rlIedrhoounreur 4ei f nxed ft

glol,zvltnlartntawx er,v mii rtrgxaeon c olftklaeau , tl eiem -eserg yatdce tbsmnlseo.ai ohauta treiscntl r-nfcrcaa iadnbimiueph iiIitufd ipbetsist apotm nolrose iy psba tsa issneDarcalsutet dsl p onnedldreit ease ltaoircpi

er,sFtdaaseidu n ioodlksrr er c ,nfrdo vypfa g eafiDye. sp i moiceeloAnhga zpenSroithhha

;&np sb

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In